Strategic Partnerships Glooko has recent integrations with Tandem Diabetes Care and Abbott, expanding device compatibility and data automation. This suggests a strong pull for healthcare providers seeking seamless device data flow into unified platforms, presenting an opportunity to upsell broader integration and enterprise analytics capabilities.

Inpatient and Outpatient Growth The company emphasizes coordinated care across outpatient and inpatient settings with solutions like EndoTool and remote monitoring. Sales opportunities exist in health systems looking to consolidate glycemic management across care settings, reducing clinician burden and improving safety.

EHR Integration Focus Recent launches such as Pump Settings EHR Integration indicate a push toward structured data within EHRs and SmartText workflows. This aligns with hospital IT initiatives to streamline documentation, offering a path to sell deeper EHR-enabled automation and data visualization.

Affordability and Scale With a sizeable total funding and revenue range, Glooko operates at scale with a broad customer base and over 200 integrated devices. This positions them to pursue large health system contracts and national accounts seeking comprehensive diabetes management at enterprise scale.

Global Expansion Accompanying the Asia and Middle East expansion, Glooko targets international markets and multinational providers. Sales teams can target health systems with cross-border needs, and partners capable of supporting regional regulatory and data residency requirements.